Publication
Blinatumomab Care Delivery for Pediatric B-Cell Acute Lymphoblastic Leukemia.
Daniel J Zheng, Katelyn Oranges, Subhash Ramakrishnan, Lingyun Ji, Melissa P Beauchemin, Sarah W Alexander, Allison Barz Leahy, Kira Bona, Emi H Caywood, Sharon M Castellino, Sumit Gupta, Douglas S Hawkins, Olga Militano, Kathleen E Montgomery, Haley Newman, Rachel E Rau, Susan Rheingold, Joanna M Robles, Michael E Roth, David Teachey, Sarah Vargas, Sue Zupanec, Susan K Parsons
- Source
- PubMed
- Retrieved
- Sep 10, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260910-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
IMPORTANCE: Blinatumomab, a novel immunotherapy administered as a 28-day continuous infusion, has fundamentally shifted the treatment paradigm for pediatric B-cell acute lymphoblastic leukemia (B-ALL) and is now considered a component of standard therapy for the most common childhood cancer.…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerLeukemiadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available